List view / Grid view
15 May 2015 | By Victoria White
The BaP combination of a cholesterol-lowering drug, bezafibrate and a contraceptive steroid could be an effective treatment for a range of cancers.
15 May 2015 | By Victoria White
Eli Lilly and Company and Sanford-Burnham Medical Research Institute are to collaborate to discover and develop immunological therapies...
14 May 2015 | By Victoria White
Novogen has confirmed that drug candidate, Anisina, is an effective monotherapy against human melanoma in an animal model...
14 May 2015 | By Victoria White
Acucela has announced the publication of preclinical data related to the Company’s investigational drug candidate emixustat hydrochloride...
14 May 2015 | By Victoria White
Antibiotic Research UK has welcomed this latest report to come from Jim O’Neill's Review on Antimicrobial Resistance and has endorses its recommendations...
13 May 2015 | By Victoria White
Immunomic Therapeutics has been awarded a US $1.2 million grant for the development of its ARA-LAMP-vax technology against peanut allergies...
13 May 2015 | By Victoria White
Under the terms of an existing agreement with Selecta, Sanofi has exercised its option to an exclusive license to develop a treatment of coeliac disease...
13 May 2015 | By Victoria White
Genethon and Selecta Biosciences have announced an ongoing research collaboration with the goal of enabling repeat dosing for gene therapies...
13 May 2015 | By Victoria White
Soligenix has initiated a development agreement with Emergent BioSolutions to implement a commercially viable, scalable production technology for RiVax...
13 May 2015 | By Victoria White
A Phase I clinical trial of INVAC-1, an innovative therapeutic DNA vaccine, which specifically targets the telomerase enzyme (hTERT), has commenced...
12 May 2015 | By
Scientists from TSRI and NIH have mapped out the structure of an important protein involved in cellular function and nervous system development - TTLL7...
12 May 2015 | By Victoria White
Mainz-based researchers have made significant advances with regard to the development of individualised cancer immunotherapy strategies...
12 May 2015 | By Victoria White
Cyclenium Pharma and Haplogen have signed a research agreement aimed at the discovery of novel pharmaceutical candidates in multiple disease areas...
12 May 2015 | By Victoria White
BioNTech and Lilly are to collaborate to identify and validate novel tumour targets and their corresponding TCRs in one or more types of cancer...
11 May 2015 | By Victoria White
Cidara Therapeutics has announced that the FDA has designated the Company’s lead antifungal product candidate, CD101 IV, as a QIDP with Fast Track status...
